Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets close in 1 hour 45 minutes
ALL ORDS
7,859.50
-72.50
(-0.91%)
ASX 200
7,597.20
-66.90
(-0.87%)
AUD/USD
0.6471
-0.0008
(-0.13%)
OIL
81.14
-0.79
(-0.96%)
GOLD
2,292.10
-10.80
(-0.47%)
Bitcoin AUD
93,108.51
-5,037.74
(-5.13%)
Corvus Pharmaceuticals, Inc. (CRVS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.5500
-0.0300
(-1.90%)
At close: 04:00PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
16,526
16,526
24,468
29,115
31,830
Selling general and administrative
6,881
6,881
8,097
9,515
11,930
Total operating expenses
23,407
23,407
32,565
38,630
43,760
Operating income or loss
-23,407
-23,407
-32,565
-38,630
-43,760
Interest expense
-
-
-
15
-
Total other income/expenses net
-5,206
-5,206
-9,396
-4,596
37,225
Income before tax
-27,029
-27,029
-41,307
-43,241
-5,995
Income from continuing operations
-27,029
-27,029
-41,307
-43,241
-5,995
Net income
-27,029
-27,029
-41,307
-43,241
-5,995
Net income available to common shareholders
-27,029
-27,029
-41,307
-43,241
-5,995
Basic EPS
-0.64
-
-0.89
-1.03
-0.20
Diluted EPS
-0.64
-
-0.89
-1.03
-0.20
Basic average shares
47,401
-
46,554
41,854
29,479
Diluted average shares
47,401
-
46,554
41,854
29,479
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.